Sign in
Taking peopleNo phase

Brain scans at rest to anticipate recovery from optic neuritis

Tests an added resting brain MRI scan in adults with optic neuritis.

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
Status
Recruiting
People taking part
200 people, planned
Started
17 Dec 2020
Expected to end
Jun 2027
Type of study
Observational, 2 groups
Treatments tested
  • MRI
  • visual acuity
Record updated
5 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with suspected optic neuritis (inflammation of the nerve of the eye) who are having an MRI scan for it. A control group of people having an MRI for other reasons also takes part.

Age
Over 18 years
Sex
All
Disease stage
Clinical suspicion of optic neuritis, with an MRI planned to look into it.

Main reasons for not taking part

  • People who cannot have an MRI scan, including pregnant or breastfeeding women
  • History of amblyopia (lazy eye)
  • Any earlier eye disease that lowers vision, such as retinitis pigmentosa or AMD
  • People under a legal protection measure

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients over 18 years of age
  • Clinical suspicion of optic neuritis
  • Benefiting from an MRI for exploration of optic neuritis
  • Affiliate or beneficiary of a social security scheme
  • Having received informed information about the study and having given their express consent to participate in the study

Who cannot take part

  • History of amblyopia
  • Contraindication to absolute or relative MRI (in particular, pregnant or breastfeeding women)
  • Any pre-existing pathology leading to a decrease in vision (e.g. retinitis pigmentosa, AMD, etc.)
  • Patient benefiting from a legal protection measure

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

When patients arrive in the waiting room of the MRI department, patients will be given the briefing note explaining the purpose of the study and how it is going. During the consultation, the radiologist will check the inclusion and non-inclusion criteria, and will take the time to answer all of the patient's questions about the study. If the patient agrees to participate in the research, the investigating doctor will obtain his consent.

Read full original descriptionShow less

The MRI examination will be performed on a 3T multi-parametric MRI. Compared to the standard protocol, patients will benefit from an additional sequence of f-mRI, called resting state, and performed before injection of gadolinium contrast agent.

A consultation with an ophthalmologist will also be carried out the same day, at the Adolphe de Rothschild Foundation. During this visit, an OCT examination (optical coherence tomography), a visual field as well as the measurement of visual acuity will be carried out, in accordance with the treatment usually practiced at the Adolphe de Rothschild Foundation.

The subjects of the control group who agreed to participate will benefit from an MRI examination which will include, in addition to the sequences planned for these patients according to their indications, the two non-injected sequences which will be performed on patients with suspected NO.

The possible existence of visual problems in the subjects of the control group will also be asked to them by interrogation. No eye exams or follow-up visits are planned, and control group participation will end after the MRI scan.

Patients with NO will be seen in consultation by an ophthalmologist during a follow-up visit approximately 6 months after diagnosis. During this consultation, an OCT, a visual field and the measurement of visual acuity will be performed. This visit and the examinations carried out correspond to the usual care of patients suffering from NO and followed at the Adolphe de Rothschild Foundation Hospital.

The 2 groups in the trial

  • optic neuritis

    Treatment: MRI and visual acuity

  • control

    Treatment: MRI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
Plain-language title
Brain scans at rest to anticipate recovery from optic neuritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
5 January 2026